AQR Capital Management
TTOO

AQR Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

AQR Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8
Closed -$111K – 2211
2019
Q1 		$111K Hold
8
– – ﹤0.01% 2130
2018
Q4 		$127K Hold
8
– – ﹤0.01% 2132
2018
Q3 		$315K Hold
8
– – ﹤0.01% 2091
2018
Q2 		$310K Buy
+8
New +$304K ﹤0.01% 2116

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AQR Capital Management's TTOO Position: Q2 2019 in Review

AQR Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q2 2019, closing a stake of 8 shares — an estimated $111K sold.

AQR Capital Management first reported a position in TTOO in Q2 2018 and held it in 4 quarters. The position peaked at $315K in Q3 2018. 63 funds tracked by Wall St. Rank hold TTOO as of Q2 2019.

  • AQR Capital Management reported no remaining T2 Biosystems, Inc position as of Q2 2019 after selling out during the quarter.
  • AQR Capital Management sold 8 T2 Biosystems, Inc shares in Q2 2019, an estimated $111K.
  • AQR Capital Management first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 4 quarters.
  • AQR Capital Management's T2 Biosystems, Inc position peaked at $315K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2019.

Based on AQR Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.